Clinical efficacy of intravitreal corticoid as an adjunctive therapy to anti-VEGF treatment of neovascular age-related macular degeneration: a Meta-analysis

Published on Jan 1, 2021in International Journal of Ophthalmology1.33
· DOI :10.18240/IJO.2021.07.19
Bo-Hao Cui , Wei Zhou (Tianjin Medical University General Hospital)+ 4 AuthorsHua Yan12
Estimated H-index: 12
(Tianjin Medical University General Hospital)
📖 Papers frequently viewed together
#1Bindu Rajesh (Khoo Teck Puat Hospital)H-Index: 7
Last. Jay Chhablani (LVPEI: L V Prasad Eye Institute)H-Index: 28
view all 16 authors...
Purpose To evaluate the real-life safety profile of intravitreal dexamethasone implant injection for various retinal conditions. Methods Retrospective multicenter analysis of intravitreal dexamethasone implant injections (700 µg) due to various retinal conditions including central retinal venous occlusion (1861 injections), diabetic macular oedema (3104 injections), post-surgical cystoid macular oedema (305 injections) and uveitis (381 injections). The eyes were evaluated mainly for the occurren...
22 CitationsSource
#1Mark C Gillies (USYD: University of Sydney)H-Index: 58
#2Alex P. Hunyor (USYD: University of Sydney)H-Index: 22
Last. Ian L. McAllister (UWA: University of Western Australia)H-Index: 38
view all 8 authors...
Importance To our knowledge, this is the first randomized clinical trial to compare visual outcomes and injection loads between ranibizumab and aflibercept using an identical treat-and-extend (TE) regimen for neovascular age-related macular degeneration (nAMD). Objective To report the results of the preplanned 12-month interim analysis of 2 predefined secondary efficacy end points of a randomized clinical trial. Design, Setting, and Participants The Comparison of Ranibizumab and Aflibercept for ...
40 CitationsSource
#1Kun Liu (SJTU: Shanghai Jiao Tong University)H-Index: 15
Last. Zhili NiuH-Index: 1
view all 20 authors...
Purpose Age-related macular degeneration (AMD) can cause irreversible vision loss leading to blindness. We aim to evaluate the efficacy and safety of intravitreal injections of 0.5 mg conbercept, a new anti–vascular endothelial growth factor (anti-VEGF) drug, for treatment of AMD on a schedule more manageable for patients. Design A prospective, double-masked, multicenter, sham-controlled, phase III randomized trial. Methods Patients : Patients with choroidal neovascularization (CNV) secondary to...
50 CitationsSource
#1Ermete Giancipoli (University of Sassari)H-Index: 8
#2Antonio Daniele Pinna (University of Sassari)H-Index: 80
Last. Giuseppe D'Amico Ricci (University of Sassari)H-Index: 6
view all 7 authors...
Purpose. To evaluate the efficacy and safety of a single intravitreal dexamethasone implant (DXI) combined with intravitreal antivascular endothelial growth factor (anti-VEGF) therapy, in patients with neovascular age-related macular degeneration (wet-AMD) resistant to conventional treatment. Methods. In this randomized, controlled pilot study, 16 eyes of 15 patients, unresponsive to anti-VEGF therapy, were enrolled and randomly assigned to two groups: DXI
7 CitationsSource
#1Preethi S. Ganapathy (Duke University)H-Index: 1
#2Careen Y. Lowder (Cleveland Clinic)H-Index: 37
Last. Sunil K. Srivastava (Cleveland Clinic)H-Index: 34
view all 7 authors...
Purpose Noninfectious uveitis has been treated historically with corticosteroid therapy in varying doses and routes. Triesence, a preservative-free sterile formulation of triamcinolone acetonide, has been used in a wide spectrum of ocular pathologies, but there have been few large studies validating its dosing or detailing long-term side effects in uveitic disease. The primary aim of this study was to describe the relative duration of action and side effects of 2 doses of preservative-free intra...
5 CitationsSource
#1Ye He (Tianjin Medical University)H-Index: 1
#2Xin-jun Ren (Tianjin Medical University)H-Index: 1
Last. Xiaorong Li (Tianjin Medical University)H-Index: 22
view all 5 authors...
Background This meta-analysis evaluated the effectiveness and safety of dexamethasone (DEX) implant and intravitreal anti-vascular endothelial growth factor (VEGF) treatment for diabetic macular edema (DME).
39 CitationsSource
#1S. K. MishraH-Index: 1
#1S. K. MishraH-Index: 1
Last. Vineet SharmaH-Index: 22
view all 7 authors...
Among the retinal vascular diseases, burden of retinal vein occlusion is most common immediately after diabetic retinopathy. Intravitreal corticosteroids are gaining popularity in managing macular edema (ME) of RVO. Our study compares efficacy and safety of intravitreal triamcinolone (IVTA) and dexamethasone implant (IVD) over 6 months. This comparative, prospective, randomized study on 40 patients of non-ischemic central RVO with significant ME (> 330 μm) of 35 mmHg and 66% needed combination t...
12 CitationsSource
#1J CuiH-Index: 1
#1Jinglin Cui (UTHSC: University of Tennessee Health Science Center)H-Index: 3
Last. H ChenH-Index: 1
view all 14 authors...
Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study
15 CitationsSource
#1Raj K. MaturiH-Index: 22
#2Adam R. GlassmanH-Index: 47
Last. Jennifer K. Sun (Harvard University)H-Index: 39
view all 11 authors...
Importance Some eyes have persistent diabetic macular edema (DME) following anti–vascular endothelial growth factor (anti-VEGF) therapy for DME. Subsequently adding intravitreous corticosteroids to the treatment regimen might result in better outcomes than continued anti-VEGF therapy alone. Objective To compare continued intravitreous ranibizumab alone with ranibizumab plus intravitreous dexamethasone implant in eyes with persistent DME. Design, Setting, and Participants Phase 2 multicenter rand...
87 CitationsSource
#1Qader Motarjemizadeh (Urmia University of Medical Sciences)H-Index: 2
#2Naser Samadi Aidenloo (Urmia University of Medical Sciences)H-Index: 4
Last. Vahid Sadrinia (Urmia University of Medical Sciences)H-Index: 1
view all 4 authors...
PURPOSE: The purpose of this study is to compare the long-term outcomes of intravitreal bevacizumab (IVB) with a combination therapy including IVB/intravitreal triamcinolone acetonide (IVB/IVTA) in neovascular age-related macular degeneration (AMD). MATERIALS AND METHODS: This prospective, randomized clinical trial was conducted on 136 eyes of 136 patients with neovascular AMD. Eyes were randomly assigned to receive IVB alone (71 eyes) or in combination with IVTA (65 eyes). In the IVB group, thr...
3 CitationsSource
Cited By0